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EXTRA-ADRENAL PHEOCHROMOCYTOMA PRESENTING
WITH LIFE-THREATENING VENTRICULAR TACHYCARDIA:
A CASE REPORT
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Extra-adrenal pheochromocytoma develops in paraganglion chromaffin cells of the sympathetic nervous
system. It probably represents at least 15% of adult and 30% of childhood pheochromocytomas. Although
electrocardiographic abnormalities occur in up to 75% of patients with pheochromocytoma, there are only
three other reported cases of pheochromocytoma that initially presented with ventricular tachycardia. In
this report, we describe a 64-year-old woman with an abdominal para-aortic extra-adrenal
pheochromocytoma who presented with pulseless ventricular tachycardia and needed electrical
defibrillation initially to keep vital signs. The 24-hour urine vanillylmandelic acid was 35.8 mg.
Computerized tomography showed a left retroperitoneal mass. The postoperative course was uneventful.
Pheochromocytoma was proved by histologic study.
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Extra-adrenal pheochromocytoma develops in paragan-
glion chromaffin cells of the sympathetic nervous system.
It probably represents at least 15% of adult and 30% of
childhood pheochromocytomas [1]. It most commonly
occurs in the second or third decade of life [2]. Patients with
extra-adrenal pheochromocytoma commonly present with
the classic triad of headache, palpitation, and sweating [2].
Cardiac arrhythmias are common with pheochromocyto-
ma. Nevertheless, ventricular tachycardia has been reported
in only three cases [3]. We report a rare case of pulseless
ventricular tachycardia caused by extra-adrenal pheo-
chromocytoma in an adult.
CASE PRESENTATION
A 64-year-old female had had hypertension under drug
control (amlodipine 2.5 mg/day and bisoprolol 5 mg/day)
for 2 years. She was sent to our emergency department due
to cold sweating, headache, palpitation, and hypertension
(245/119 mmHg). She lost consciousness and had pulse-
less ventricular tachycardia (Figure 1) after arrival. After
electrical defibrillation (200 J), she recovered consciousness.
Electrocardiography (ECG) showed sinus tachycardia and
inverted T waves. Blood pressure was 237/160 mmHg. Due
to unstable hemodynamics, she was admitted and received
advanced survey.
A 24-hour Holter monitor revealed sinus rhythm with
intermittent junctional escape rhythms. Heart ultrasono-
graphy showed mild tricuspid regurgitation, right ven-
tricular dilation, and septal hypertrophy. The patient
also underwent coronary angiographic evaluation, which
was normal. The 24-hour urine vanillylmandelic acid was
35.8 mg (normal, 2–9 mg/24 hours). Other laboratory studies
revealed: normal thyroid function; serum ionized calcium,
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4.9 mg/dL; normal serum electrolyte; blood urea nitrogen,
27 mg/dL; and creatinine, 1.2 mg/dL. Computerized
tomography showed a left retroperitoneal mass which
compressed the left ureter, resulting in mild obstructive
uropathy (Figure 2). 131I-metaiodobenzylguanidine scan
revealed abnormal tracer uptake in the left abdomen. After
admission, blood pressure and arrhythmia were well con-
trolled with labetalol, a non-selective α- and β-adrenergic
blocker. Preoperatively, the patient was taking 200 mg
labetalol three times daily, titrated to 200 mg twice daily
according to blood pressure when surgery was arranged.
The tumor was totally excised through a para-midline
transperitoneal incision. An operative ECG-blood pres-
sure monitor taped several hypertensive and hypoten-
sive episodes without ventricular rhythm disturbance.
Histopathologic examination of the tumor confirmed
pheochromocytoma (weight, 32 g; 62 × 39 × 28 mm) (Fig-
ure 3). Postoperatively, blood pressure remained stable
and within the normal range. She was discharged on
postoperative day 14.
DISCUSSION
Electrocardiographic abnormalities are common and occur
in up to 75% of patients with pheochromocytoma, including
sinus tachycardia, premature ventricular complex, T-wave
inversion, premature atrial complex, ST elevation, parox-
ysmal supraventricular tachycardia, atrial fibrillation,
prolonged QT interval, painless myocardial infarction, and
left ventricular hypertrophy [3]. However, pheochromo-
cytoma that initially presents with ventricular tachy-
cardia is rare and only three cases have been reported in
the literature [4]. We report another case of extra-adrenal
pheochromocytoma that presented with pulseless ven-
tricular tachycardia and needed electrical defibrillation.
Cardiac arrhythmias are probably due to the sudden
release of catecholamines. Ceremuzynski et al found
increased plasma catecholamine concentrations in anes-
thetized dogs during acute myocardial ischemia and a
relationship between blood catecholamine concentration
and the severity of ventricular arrhythmias [5]. Daugherty
et al showed that increases in plasma catecholamine
concentrations during coronary artery ligation in
pentobarbitone-anesthetized rats were prevented by either
acute adrenalectomy or chronic adrenal demedullation,
but these procedures did not protect against ventricular
arrhythmias [6]. Thus, plasma catecholamines are not
obligatory mediators of arrhythmogenesis, but these results
do not exclude the possibility that catecholamines released
locally to the ischemic myocardium may be important
arrhythmogenic mediators.
Other neurohumoral agents may be associated with
cardiac arrhythmia. Neuropeptide Y levels are increased in
the plasma and tumors of patients with pheochromocytoma.
Neuropeptide Y has potent direct and indirect cardio-
vascular effects [7]. The presence and degree of circulatory
disturbance, in particular tachycardia and left heart failure,
are strongly related to increased plasma concentrations of
neuropeptide Y in coronary care patients [8].
Figure 1. Ventricular tachycardia on electrocardiography.
Figure 2. A left retroperitoneal mass (arrow) on computerized
tomography.
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In addition, cardiac abnormalities occur commonly in
patients with pheochromocytomas, including myocarditis,
acute myocardial infarction, cardiac arrhythmias, and
cardiomyopathy. Catecholamines released from pheo-
chromocytomas cause myocardial necrosis, focal
myofibrillar degeneration, and subsequent fibrous scar
formation [9,10].
The preoperative use of phenoxybenzamine, a non-
selective α-adrenergic blocker, has a mostly theoretical
pharmacologic basis. The β-blocker propranolol is used
when tachycardia or catecholamine-induced arrhythmias
are present, and should only be started after α-blockade has
been established to avoid life-threatening hypertension.
Labetalol has the advantage of being a β-blocker with
additional α-adrenergic blocking properties. However, it
may interfere with diagnostic studies, restricting its use to
patients in whom the diagnosis of pheochromocytoma is
already firm [1,7]. The optimal length of preoperative
adrenergic blockade is variable and primarily depends on
the time required for the patient to manifest hemodynamic
stability. In our case, the patient was placed on labetalol
2 weeks preoperatively to control hypertension and
tachycardia.
Pheochromocytoma should be kept in mind even in an
elderly hypertensive patient. In our opinion, while the di-
agnosis of extra-adrenal pheochromocytoma is established
by biochemical examination and image studies, it is best to
use continuous ECG monitoring. Although life-threatening
cardiac arrhythmias are rare in extra-adrenal pheo-
chromocytoma, cardiopulmonary resuscitative facilities and
Figure 3. Microscopic findings of the retroperitoneal mass: (A) tumor cells are arranged in a nest bounded by delicate fibrovascular stroma, the so-
called Zellballen (hematoxylin & eosin, × 40); (B) the nuclei are round or oval with finely granular cytoplasm, and there is hyperchromasia with
occasional nucleoli (hematoxylin & eosin, × 400).
medications must be easily available to prevent morbidity
and cardiac arrest.
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